Integer Holdings shareholders voted to approve the company's $5.7 billion acquisition by funds managed by KKR, clearing the final governance milestone for the private equity firm's largest medtech transaction in three years. The vote, conducted at a special shareholder meeting, came seven weeks after KKR announced the all-cash deal at $126.50 per share, a 31% premium to Integer's 30-day volume-weighted average price at announcement.
Integer manufactures cardiac rhythm management components, vascular access systems, and portable power sources for medical devices. The Plano, Texas-based company reported $1.6 billion in trailing twelve-month revenue across 60 facilities in 13 countries. KKR's acquisition price implies a multiple near 12.5x enterprise value to forward EBITDA, consistent with recent private equity appetite for diversified medical component suppliers with exposure to both implantable and externally-worn device categories. The shareholder approval rate exceeded 96% of votes cast, according to preliminary tallies disclosed in regulatory filings.
The approval removes the last material condition precedent beyond standard regulatory clearance. Integer's business sits at the intersection of three allocation themes: aging demographics driving structural cardiac device demand, medtech supply chain consolidation, and the shift toward outsourced component manufacturing among branded OEMs. KKR inherits revenue streams from customers including Medtronic, Abbott, and Boston Scientific, with approximately 42% of Integer's sales tied to cardiac neuromodulation and 31% to cardio and vascular applications. The business carries mid-teens EBITDA margins and generates consistent free cash flow, characteristics that support leverage levels typical of healthcare services LBOs.
Operators should monitor two items in the next 45 to 60 days: first, Hart-Scott-Rodino antitrust clearance from the Federal Trade Commission, which typically passes without incident for supplier-side medtech deals but can extend timelines if secondary requests emerge; second, any credit agreement amendments or refinancing activity visible in syndicated loan databases, as KKR will likely pursue leverage closer to 5.5x to 6.0x adjusted EBITDA to finance the purchase. The transaction is expected to close in the second quarter, barring unforeseen regulatory friction.
Integer will delist from the New York Stock Exchange within 10 business days of the transaction close. KKR's medtech portfolio already includes Covetrus veterinary supply and Envision Healthcare physician staffing, positioning Integer as the anchor asset in a potential healthcare industrials platform strategy.
The takeaway
Shareholder approval at 96%+ removes governance risk from KKR's $5.7B Integer LBO; regulatory clearance and credit markets are the remaining variables.
Editorial & Disclosure Notice: This article was written with artificial intelligence from public sources and is published without individual human review. Artificial intelligence and other digital tools are also used for research, analysis, editing, formatting, and production. Errors, omissions, outdated information, or inaccuracies may occur. References to companies, brands, products, services, organizations, or individuals are for informational and editorial purposes and do not imply endorsement, sponsorship, affiliation, partnership, or approval unless expressly stated. All trademarks and other intellectual property remain the property of their respective owners. Opinions, analysis, estimates, and commentary are informational only and should not be construed as financial, investment, legal, tax, medical, procurement, or other professional advice. Information may be corrected, clarified, or updated after publication. Corrections or removal requests: jenny@pops4.com.
Want the 60-second program for your specific event?
Enter your event and email — we build it and send the branded proposal before lunch. No obligation.
The branded-identity layer Chiefs of Staff and heritage CMOs route through — your name imprinted on real authorized stock, your pick of 200+ brands and 70,000 products, shipped from one accountable house. Nine editorial desks publish the intelligence those operators read before they sign.
200+authorized brands
70,000products · virtual proof on each
9 deskspublishing daily
1997one house, since
70,000 SKUs · virtual proof in 60 seconds · no platform fee · blind-shipped · ASI #217876
Your next customer won't visit your website. Their AI will.
AI assistants have quietly taken over the first step of buying — they answer from catalogs they can read and shortlist whoever can actually ship. Two questions now decide whether you exist to that buyer: can a machine read your catalog, and can you fulfill the order. Most brands fail one or both and never find out why the orders went elsewhere. The winners of this shift aren't the loudest. They're the most readable. Build for the machine that's about to do the shopping.
Built by the craft floor — apparel, media, packaging, and secure print.
This trade runs on hands, not desks. Imprint manufacturing & Komori heritage press through approved vendors · Canon high-speed secure-media operations is a craft floor — genuine Six Sigma discipline applied to ink, thread, foil, and registration, where a hundredth of an inch is the difference between a brand that reads serious and one that reads cheap. POPS4 is built by exactly those operators: independent, boots-on-the-ground engineers who carry their own book, read a client in microseconds, and put their name on every run. Beyond our own Virginia Beach floor, we work with a vetted network of craft manufacturers across the US — each meeting the highest excellence in QC standards in the industry, each a specialist in its own discipline — so apparel, hard-goods imprinting, media manufacturing, packaging, and secure printing all go to the bench built for them, coordinated from one accountable hub. Short-run from twenty-five units, volume to five hundred thousand. Two hundred authorized national brands, seventy thousand SKUs with virtual proofing on every one. Art archived for instant reorders. Net-thirty corporate terms, NDA-standard white-label — your name on the work, or none at all.
Strategy, positioning, identity, creative, and messaging — wired into an AI system that publishes and distributes on its own. Nine editorial desks generate the authority, the production house ships the physical proof, and the attribution layer tells you which post sold which SKU. What you get is an operating layer — content, catalog, and order path under one roof — that keeps working whether or not you are in the room. Built for principals who would rather own the machine than rent the agency.
Named-account programs — one desk, quiet delivery, NDA-standard.
One point of contact who already knows the file, so nothing restarts from zero between engagements. The work ships blind, under NDA, with your name on it or none at all. Built for single-family offices, heritage-house CMOs, sports-ownership groups, and the agencies that white-label our production. The relationship is the product; the merch is the proof of it.
SFO · Chief of Staff desk. Principal household, properties, aircraft, yacht, calendar, philanthropy — one file.
Shop seventy thousand products. Virtual proof on every one. 24/7.
Drop your logo on any product and see the virtual proof before asking. Quote routes direct to the desk. MCP catalog for AI agents. Celeste for the fast conversation. Full self-service checkout in development.